Puig Brands saw shares jump 15% Tuesday after Estée Lauder Companies confirmed ongoing negotiations regarding a potential merger. The announcement follows initial reporting by the Financial Times, though Estée Lauder clarified late Monday that no final decision exists and financial terms remain undisclosed.

The market reaction was immediate. Puig closed up 14.6%, while Estée Lauder gained less than 1% in premarket trading, recovering slightly after a 7.7% drop in the previous session. The deal would unite Estée Lauder's $28.7 billion market cap with Puig's €8.8 billion valuation, consolidating major portfolios including Tom Ford Beauty, Clinique, and Charlotte Tilbury under one entity.

For Estée Lauder, the move signals an aggressive pivot during a difficult turnaround. The company has implemented layoffs and warned that U.S. tariffs would reduce full-year profitability by $100 million. Shares remain down 24% year-to-date. Conversely, Puig has demonstrated steady sales growth since its 2024 public listing, managing a portfolio spanning fragrance, skin care, and makeup.

Beyond finance, the integration complexity presents significant hurdles. Citi pointed out that investors often penalize large-scale deals, citing recent volatility in consumer goods mergers. While Deutsche Bank observed that Estée Lauder's stock price reflects market apprehension, analysts led by Filippo Falorni project potential synergies equal to 5% of target sales and double-digit earnings per share growth in year one. However, they warn that execution risk remains high. Currently, the data suggests investors are betting heavily on Puig's growth trajectory over Estée Lauder's ongoing restructuring efforts amid the current economic climate.

Source: CNBC